Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Total Current Liabilities (2021 - 2025)

Historic Total Current Liabilities for Neuphoria Therapeutics (NEUP) over the last 5 years, with Q4 2025 value amounting to $2.6 million.

  • Neuphoria Therapeutics' Total Current Liabilities rose 2121.38% to $2.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.6 million, marking a year-over-year increase of 2121.38%. This contributed to the annual value of $4.2 million for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q4 2025, Neuphoria Therapeutics' Total Current Liabilities is $2.6 million, which was up 2121.38% from $5.1 million recorded in Q3 2025.
  • In the past 5 years, Neuphoria Therapeutics' Total Current Liabilities ranged from a high of $5.1 million in Q3 2025 and a low of $1.6 million during Q1 2025
  • Moreover, its 5-year median value for Total Current Liabilities was $2.6 million (2024), whereas its average is $2.9 million.
  • In the last 5 years, Neuphoria Therapeutics' Total Current Liabilities soared by 1482.62% in 2023 and then soared by 10081.71% in 2025.
  • Quarter analysis of 5 years shows Neuphoria Therapeutics' Total Current Liabilities stood at $2.4 million in 2021, then dropped by 0.43% to $2.4 million in 2022, then increased by 14.83% to $2.8 million in 2023, then decreased by 22.69% to $2.1 million in 2024, then grew by 21.21% to $2.6 million in 2025.
  • Its Total Current Liabilities was $2.6 million in Q4 2025, compared to $5.1 million in Q3 2025 and $4.2 million in Q2 2025.